Acerus Pharmaceuticals (TSE:ASP) will be announcing its earnings results before the market opens on Thursday, November 14th.

TSE ASP opened at C$0.08 on Tuesday. The stocks fifty day moving average is C$0.10 and its two-hundred day moving average is C$0.12. The firm has a market capitalization of $20.90 million and a P/E ratio of -1.25. The company has a debt-to-equity ratio of 105.08, a quick ratio of 0.40 and a current ratio of 0.74. Acerus Pharmaceuticals has a fifty-two week low of C$0.07 and a fifty-two week high of C$0.21.

About Acerus Pharmaceuticals

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.

Recommended Story: Market Capitalization and Individual Investors

Read the original here:
Acerus Pharmaceuticals (ASP) Set to Announce Earnings on Thursday - Polson News

Comments are closed.